Relapsed Leukemia and Lymphoma Program News and Updates FDA Approves Personalized Cellular Therapy for Advanced Leukemia Developed by University of Pennsylvania and Children’s Hospital of Philadelphia This is a game changer for the treatment of pediatric patients battling leukemia and a pivotal milestone in this fresh era of cellular therapies that treat cancer with a patient`s own immune system.

Read More »